Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -183,174 | -287,216 | -239,238 | -187,134 | -130,403 |
| Depreciation Amortization | 10,367 | 10,598 | 9,408 | 5,885 | 1,153 |
| Accounts receivable | -82,463 | -47,181 | -57,121 | -37,699 | N/A |
| Accounts payable and accrued liabilities | -6,460 | 31,318 | 2,074 | 25,456 | -355 |
| Other Working Capital | -23,058 | 33,478 | -28,238 | 22,552 | -858 |
| Other Operating Activity | 191,383 | 130,593 | 168,035 | 54,429 | 22,237 |
| Operating Cash Flow | $-93,405 | $-128,410 | $-145,080 | $-116,511 | $-108,226 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -480 | -270 | -582 | -702 | -308 |
| Net Acquisitions | N/A | N/A | N/A | -53,000 | N/A |
| Investing Cash Flow | $-480 | $-270 | $-582 | $-53,702 | $-308 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 330,000 | N/A | 85,000 | 45,000 | N/A |
| Debt Repayment | -334,112 | -990 | N/A | N/A | N/A |
| Common Stock Issued | 127,462 | 71,464 | 271,169 | 250,014 | 11,838 |
| Other Financing Activity | -21,885 | -12,634 | -25,156 | -10,432 | -708 |
| Financing Cash Flow | $101,465 | $57,840 | $331,013 | $284,582 | $11,130 |
| Beginning Cash Position | 315,353 | 386,193 | 200,842 | 86,473 | 183,877 |
| End Cash Position | 322,933 | 315,353 | 386,193 | 200,842 | 86,473 |
| Net Cash Flow | $7,580 | $-70,840 | $185,351 | $114,369 | $-97,404 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93,405 | -128,410 | -145,080 | -116,511 | -108,226 |
| Capital Expenditure | -480 | -270 | -582 | -702 | -308 |
| Free Cash Flow | -93,885 | -128,680 | -145,662 | -117,213 | -108,534 |